To study whether CELSR2 serves as a potential receptor of WNT ligands to impact the development of glioma cells, WNT3A, WNT5A and WNT1 were administered to cultured U87 MG cells transfected without or with CELSR2-shRNA (CELSR2 KD). The gene discussed is WNT5A; the disease is glioma.